SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-046360
Filing Date
2020-04-14
Accepted
2020-04-14 16:06:48
Documents
5
Period of Report
2020-04-14
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2015825d1_8k.htm 8-K 23114
2 EXHIBIT 3.1 tm2015825d1_ex3-1.htm EX-3.1 8443
3 EXHIBIT 99.1 tm2015825d1_ex99-1.htm EX-99.1 13598
4 GRAPHIC image_002.jpg GRAPHIC 3405
5 GRAPHIC image_001.jpg GRAPHIC 1684
  Complete submission text file 0001104659-20-046360.txt   53794
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 20791435
SIC: 2834 Pharmaceutical Preparations